EAGLE BANCORP INC (EGBN) Stock News
NASDAQ:EGBN - Nasdaq - US2689481065 - Common Stock - Currency: USD
EGBN Latest News, Press Relases and Analysis
Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Eagle...
Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Eagle...
New Strong Sell Stocks for June 5th
ENTG, EGBN and BRTHY have been added to the Zacks Rank #5 (Strong Sell) List on May 5 2025.
Mentions: ENTG
New Strong Sell Stocks for April 1st
AMR, APPF and EGBN have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2025.
Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Eagle...
Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Eagle...
Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Biotech Stocks with Huge Upside Potential. Tessa Romero, an analyst at JPMorgan, has maintained her Overweight rating on Cytokinetics, Incorporated (NASDAQ:CYTK) but reduced the firm’s price objective from $71 to $53. Aficamten’s revised revenue projections, which anticipate a slower launch trajectory, are the basis for the modification. […]
Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James
Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started coverage of Avidity Biosciences, Inc. (NASDAQ:RNA), with a Strong Buy rating and a price objective of $65. The rating is part of a larger biotech sector note, in which the firm sees favorable risk/reward across the […]
Why Oklo Stock Rocketed Almost 30% Higher Today
This would take the form of a power plant project in Alaska. Wednesday morning Oklo announced, no doubt with great pleasure, that it had received a notice of intent to award (NOITA) for a project in Alaska. The company was notified by the government's Defense Logistics Agency on behalf of the Air Force and the Department of Defense.
McDonald’s downgraded on GLP-1 drug worries: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Lake Street upgraded Limoneira (LMNR) to Buy from Hold with an unchanged price target of $23. Q2 results came in “modestly below” the firm’s estimates behind an especially weak lemon market, but the highlight was a major agreement to merge a portion of Limoneira’s operations into Sunkist, which will “m
McDonald's downgraded on GLP-1 drug worries: Wall Street's top analyst calls
McDonald's downgraded on GLP-1 drug worries: Wall Street's top analyst calls
Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Eagle...
Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Eagle...
Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...
Eagle Bancorp, Inc. (EGBN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Eagle Bancorp, Inc. (EGBN) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Eagle Bancorp, Inc. – EGBN
Compared to Estimates, Eagle Bancorp (EGBN) Q1 Earnings: A Look at Key Metrics
The headline numbers for Eagle Bancorp (EGBN) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Eagle Bancorp (EGBN) Misses Q1 Earnings and Revenue Estimates
Eagle Bancorp (EGBN) delivered earnings and revenue surprises of -86.96% and 2.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: FMBH
Eagle Bancorp, Inc. Announces First Quarter 2025 Results and Cash Dividend
BETHESDA, Md., April 23, 2025 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (
Eagle Bancorp Announces Earnings Call on April 24, 2025
BETHESDA, Md., April 09, 2025 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company for EagleBank,...
SolaREIT Expands Revolving Credit Facility to $60 Million with Atlantic Union Bank and EagleBank
/PRNewswire/ -- SolaREIT™, the leading solar and battery storage real estate investment company, announced today the expansion of its revolving credit facility...
Mentions: AUB
Eagle Bancorp, Inc. Announces Fourth Quarter 2024 Results and Cash Dividend
BETHESDA, Md., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (
Eagle Bancorp, Inc. Announces Final Results of its Exchange Offer for its Outstanding 10.00% Senior Notes Due 2029
BETHESDA, Md., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (NASDAQ: EGBN) (“Eagle”) announced today that as of 5:00 p.m., New York City time,...
Eagle Bancorp, Inc. Announces Extension of Registered Exchange Offer for its Outstanding 10.00% Senior Notes due 2029
BETHESDA, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (NASDAQ: EGBN) (“Eagle”) today announced that (i) the expiration date has been...
EagleBank Adds New Market Executive and Two Relationship Managers to C&I Lending Team
Addition of experienced bankers in the DMV region complements EagleBank’s C&I growth strategy...
Eagle Bancorp Announces Earnings Call on January 23, 2025
BETHESDA, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company for EagleBank,...
Eagle Bancorp, Inc. Announces Registered Exchange Offer for its Outstanding 10.00% Senior Notes due 2029 Issued in Connection with Prior Private Placement
BETHESDA, Md., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (NASDAQ: EGBN) (“Eagle”) today announced the commencement of its offer to exchange...
Eagle Bancorp to Participate in the Jefferies Bank Summit
Bethesda, MD, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company of EagleBank, one...